Menopause Age and Brain Health: What a New Study Found

If you went through menopause earlier than average, a large new study suggests it’s worth factoring into your brain health plan. It’s a reason to pay closer attention to brain-health basics, not a forecast. The most useful moves: make sure your clinician knows your menopause age and type, and get serious about the brain-health basics you can control, starting with blood pressure.

What the study found

Researchers at UCSF and Rush followed 2,603 older women from two long-running US aging studies, the Religious Orders Study and the Rush Memory and Aging Project, for up to 18 years. The women averaged 78 years old at enrollment and had no known dementia when they joined. Each year they took a battery of memory and thinking tests, and 774 of them also had repeat MRI scans.^[1]

Compared with women who reached menopause later, women who reached it earlier had, on average:

• Slightly faster decline in thinking and memory. Overall cognition and episodic memory (your memory for events and experiences) declined a little faster with each year-earlier menopause.
• An earlier Alzheimer’s diagnosis. The authors estimate about 1.8 fewer Alzheimer’s-free years for a woman whose menopause came 10 years earlier.
• Faster buildup of white matter hyperintensities, but only after natural menopause. In women whose menopause was spontaneous rather than surgical, menopause 5 years earlier was linked to roughly 15% more white matter hyperintensity volume over a decade, if the peak difference held.

The link with overall brain shrinkage was there, but it was smaller than what statisticians usually count as even a small effect, and the authors say to read it cautiously.^[1]

Why white matter hyperintensities matter

White matter hyperintensities are bright spots on certain MRI scans. They often reflect damage to the small blood vessels that feed the brain’s white matter, the wiring that connects different brain regions. A 2010 meta-analysis that pooled 22 of the 46 long-term studies reviewed found that people with these spots had a higher risk of stroke (about 3.3 times), dementia (about 1.9 times) and death (about 2 times).^[2] They become more common with age, and having some isn’t a diagnosis. But it does point to blood vessel health as part of the story, and that part is something you can work on.

What this study can’t tell you

• It shows a link, not a cause. The authors raise the possibility of reverse causation: early menopause may be a sign of faster whole-body aging rather than the thing driving brain changes. Menopause timing also overlaps with sleep problems, sleep apnea, mood changes and heart and metabolic health, all of which affect the brain.
• These are small, average effects. The yearly differences in thinking scores were tiny. Plenty of women with early menopause keep sharp minds into old age. The results describe a group, not you.
• The sample was narrow. About 92% of participants were white, they averaged 16 years of education, and many were Catholic nuns. Menopause age was self-reported decades after the fact, and the women who got MRI scans were healthier than the group overall.
• Natural and surgical menopause looked different. The thinking and Alzheimer’s links were directionally stronger after surgical menopause, while the white matter link showed up only after natural menopause.

What about hormone therapy? In exploratory analyses, hormone therapy use did not significantly change how menopause age related to brain volume. The authors caution that few women in this older cohort used it in the way current guidelines describe, so the study can’t settle the question either way.^[1] Timing seems to matter, which is the idea behind the timing hypothesis. The Menopause Society’s 2022 position statement says the benefit-risk balance looks less favorable for women who start hormone therapy after age 60 or more than 10 years after menopause, partly because of higher absolute risks of heart disease, stroke, blood clots and dementia.^[3] The same statement adds that, in the absence of more definitive findings, hormone therapy is not recommended at any age to prevent or treat a decline in cognitive function or dementia.^[3] Whether it makes sense for you is a decision to make with a clinician who knows your history.

What to do with this

• Write down your menopause age and type. Note the age your periods stopped and whether it happened naturally or after surgery to remove both ovaries. If you had a hysterectomy, note that too: removing the uterus stops periods but doesn’t by itself bring on menopause. Make sure it’s in your medical record. If you want help framing the conversation, here’s how to talk to your doctor about menopause symptoms.
• Know your blood pressure. In the SPRINT MIND MRI study, adults 50 and older with high blood pressure were randomly assigned a systolic target under 120 or under 140. Over about four years, white matter lesion volume grew by 0.92 cm³ in the lower-target group versus 1.45 cm³ in the standard group. The differences were small, and total brain volume dropped slightly more in the lower-target group.^[4] Ask your clinician what target is right for you.
• Work the modifiable list. The 2024 Lancet Commission on dementia names 14 modifiable risk factors: less education, hearing loss, high blood pressure, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol, traumatic brain injury, air pollution, social isolation, untreated vision loss and high LDL cholesterol.^[5] Pick the one you’re furthest from and start there. Our list of everyday habits associated with brain health is a practical place to begin.
• Speak up about memory changes. If you notice new trouble with memory or word-finding, mention it early rather than waiting for a routine visit.

Your menopause age is one more data point, and a useful one because you know it decades before any brain changes would show. If you went through early or surgical menopause, or you’re worried about your memory, talk with a qualified clinician about your own risk and what to check.

References

[1] Campagna MP, Schneider JA, Barnes LL, Arfanakis K, et al. Age at Menopause and Brain Atrophy Among Older Women. JAMA Netw Open, 2026;9(8):e2630973. Population: 2,603 women (mean enrollment age 78.3) in the Religious Orders Study and Rush Memory and Aging Project, up to 18 years of follow-up; 774 with serial 3T MRI. DOI: https://doi.org/10.1001/jamanetworkopen.2026.30973. Finding as used: earlier menopause age was associated with faster global cognitive decline (β = -0.0009 SD per year) and episodic memory decline (β = -0.0014), and earlier Alzheimer disease diagnosis (time ratio 0.998 per year; about 1.8 fewer AD-free years for menopause 10 years earlier); in spontaneous menopause, earlier menopause was associated with faster white matter hyperintensity accumulation (about 15% greater volume over a decade for menopause 5 years earlier, assuming the peak differential is sustained); the total brain volume association fell below the threshold for a small effect; exploratory analyses found no significant moderation by menopausal hormone therapy, with low use per modern guidelines; limitations include self-reported menopause age and possible reverse causation; 92.2% of participants were White. ↑︎

[2] Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 2010;341:c3666. Population: 46 prospective longitudinal studies (22 in the meta-analysis). DOI: https://doi.org/10.1136/bmj.c3666. Finding as used: white matter hyperintensities were associated with increased risk of stroke (HR 3.3, 95% CI 2.6-4.4), dementia (HR 1.9, 95% CI 1.3-2.8) and death (HR 2.0, 95% CI 1.6-2.7). ↑︎

[3] The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022;29(7):767-794. Population: expert consensus position statement. DOI: https://doi.org/10.1097/GME.0000000000002028. Finding as used: for women who initiate hormone therapy more than 10 years from menopause onset or who are older than 60, the benefit-risk ratio appears less favorable because of greater absolute risks of coronary heart disease, stroke, venous thromboembolism and dementia; treatment should be individualized; and, in the absence of more definitive findings, hormone therapy is not recommended at any age to prevent or treat a decline in cognitive function or dementia (Level I; p. 777). ↑︎

[4] SPRINT MIND Investigators for the SPRINT Research Group; Nasrallah IM, Pajewski NM, Auchus AP, et al. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA, 2019;322(6):524-534. Population: hypertensive adults 50 or older without diabetes or stroke; 670 with baseline MRI, 449 with follow-up MRI at a median of 3.97 years. DOI: https://doi.org/10.1001/jama.2019.10551. Finding as used: white matter lesion volume increased by 0.92 cm³ with a systolic target under 120 mm Hg versus 1.45 cm³ with a target under 140 mm Hg (between-group difference -0.54 cm³); total brain volume decreased slightly more with the intensive target (between-group difference -3.7 cm³); differences were small. ↑︎

[5] Livingston G, Huntley J, Liu KY, Costafreda SG, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet, 2024;404(10452):572-628. Population: commission review prioritizing systematic reviews and meta-analyses. DOI: https://doi.org/10.1016/S0140-6736(24)01296-0. Finding as used: modifiable dementia risk factors are less education, hearing loss, hypertension, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol consumption, traumatic brain injury, air pollution and social isolation, with untreated vision loss and high LDL cholesterol added in the 2024 report. ↑︎

Kurt Greiner

Kurt is a digital strategist and IT professional blending emerging technology with practical application to help businesses and individuals streamline their digital presence. His current work focuses on the intersection of intentional living and technological resilience, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.